Summary
In the present study we investigated the capability of human epidermal cells to generate granulocyte-activating mediators (GRAM). It could be shown that human epidermal cells as well as an epidermoid carcinoma cell line (A431) produce an epidermal cell-derived granulocyte-activating mediator (EC-GRAM) which stimulates human granulocytes to release significant levels of toxic oxygen radicals as measured by a lucigenin-dependent chemiluminescence (CL). For further characterization of EC-GRAM the A431 cell line was used. Supernatants of A431 cells usually contained maximal EC-GRAM levels within 24 h of incubation. Factor production was enhanced by bacterial lipopolysaccharide (LPS), but not by silica particles and PHA. Moreover, freeze-thaw lysates of A431 cells and extracts of heat-separated human epidermis contained significant levels of EC-GRAM. Preincubation of granulocytes with EC-GRAM resulted in an enhanced response to subsequent stimulation with the chemotactic peptide f-met-phe. In contrast EC-GRAM did not affect the response to PMA or zymosan particles. However, EC-GRAM treated granulocytes were unresponsive to restimulation with EC-GRAM. Upon high performance liquid chromatography (HPLC) gel filtration EC-GRAM eluted within two major peaks exhibiting a molecular weight of 17 kD and 44 kD. According to its biochemical and biological properties EC-GRAM can be separated from other cytokines such as ETAF/-interleukin 1, interleukin 2, interferons, granulocyte colony-stimulating factor (G-CSF) and tumor necrosis factor (TNF). However, an antibody to human GM-CSF neutralized about 75% of the activity. These results indicate that EC-GRAM activity stimulating the generation of reactive oxygen species by granulocytes is probably due to GM-CSF.
Similar content being viewed by others
References
Danner M, Luger TA (1987) Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity. J Invest Dermatol 88:353–361
Danner M, Kapp A, Micksche M, Luger TA (1987) Human epidermal cell derived leukocyte stimulating activity (ELSA): a distinct unique cytokine with multiple immunological functions. Lymphokine Res 6: Abstr 1309
Eisinger M, Lee JS, Hefton JM, Darzynkiewicz Z, Chiao JW, DeHarven E (1979) Human epidermal cell cultures: growth and differentiation in the absence of dermal components or medium supplements. Proc Natl Acad Sci USA 76:5340–5344
Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte-activating factor/interleukin 1 in normal stratum corneum. J Clin Invest 76:1585–1591
Galanos C, Lüderitz O (1975) Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem 54:603–610
Hauser C, Saurat JH, Jaunin F, Sizonenko S, Dayer J-M (1985) Cultured human epidermis cells produce cell-associated interleukin 1-like prostaglandin E2- and collagenase-stimulating factors. Biochem Biophys Acta 840:350–355
Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer J-M (1986) Interleukin 1 is present in normal human epidermis. J Immunol 136:3317–3323
Kapp A, Luger TA, Maly FE, Schöpf E (1986) Granulocyte-activating mediators (GRAM). I. Generation by lipopoly-saccharide-stimulated mononuclear cells. J Invest Dermatol 86:523–528
Kapp A, Danner M, Luger TA (1987) Recombinant human granulocyte-macrophage colony-stimulating factor stimulates the release of toxic oxygen radicals by human PMN. J Invest Dermatol (in press)
Kassis V, Sondergaard J (1982) Heat separation of normal human skin for epidermal and dermal prostaglandin analysis. Arch Dermatol Res 273:301–306
Kirchner H, Kleinicke C, Digel W (1982) A whole-blood technique for testing production of human interferon by leucocytes. J Immunol Meth 48:213–219
Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti KM, Waltersdorph AM (1986) Stimulation of neutrophils by tumor necrosis factor. J Immunol 136: 4220–4225
Kownatzki E, Kapp A, Uhrich S (1986) Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocyte. Clin Exp Immunol 64:214–222
Luger TA, Oppenheim JJ (1983) Characteristics of interleukin 1 and epidermal cell-derived thymocyte-activating factor. In: Weissmann G (ed) Advances in inflammation research. Raven Press, New York, pp 1–25
Luger TA, Stadler BM, Katz SI, Oppenheim JJ (1981) Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol 127:1493–1498
Luger TA, Stadler BM, Luger BM, Mathieson BJ, Mage M, Schmidt JA, Oppenheim JJ (1982) Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol 128:2147–2152
Luger TA, Charon JA, Colot M, Micksche M, Oppenheim JJ (1983) Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 131:816–820
Luger TA, Stadler BM, Luger BM, Sztein MB, Schmidt JA, Hawley-Nelson P, Grabner G, Oppenheim JJ (1983) Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol 81:187–193
Luger TA, Uchida A, Köck A, Colot M, Micksche M (1985) Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. J Immunol 134:2477–2483
Luger TA, Kapp A, Micksche M, Danner M (1987) Characterization of a distinct epidermal cytokine with multiple immuno-regulatory properties. J Invest Dermatol 88:504
Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda N, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415–418
Rheinwald JG, Beckett MA (1980) Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22:629–632
Sauder DN (1984) Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF). Lymphokine Res 3:145–151
Sauder DN, Carter C, Katz SI, Oppenheim JJ (1982) Epidermal cell production of thymocyte-activating factor (ETAF). J Invest Dermatol 79:34–39
Sauder DN, Mounessa NL, Katz SI, Dinarello CA, Gallin JI (1984) Chemotactic cytokines: the role of leucocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J Immunol 132:828–832
Schröder JM, Christophers E (1986) Identification of C5adesarg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87:53–58
Schuff-Werner P, Scheurich P, Gottsmann K, Pfizenmaier K, Nagel CA (1987) MLC-derived chemiluminescence enhancing activity on polymorphonuclear neutrophils: TNF-alpha as an active principle. In: Schölmerich J, Andreesen R, Kapp A, Ernst M, Wood WG (eds) Bioluminescence and chemiluminescence — new perspectives. Wiley, Chichester, pp 129–132
Schuler G, Steinman RM (1985) Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161:526–546
Schwarz T, Urbanska A, Gschnait F, Luger TA (1986) Inhibition of contact hypersensitivity by an UV-mediated epidermal cytokine. J Invest Dermatol 87:289–291
Stingl G, Tamaki K, Katz SI (1980) Origin and function of epidermal Langerhans cells. Immunol Rev 53:149–174
Vadas MA, Nicola NA, Metcalf D (1983) Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Immunol 130:795–799
Vadas MA, Nicola NA, Lopez AF, Metcalf D, Johnson G, Pereira A (1984) Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol 133:202–207
Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC (1985) Human granulocyte-macrophage colony-stimulating factor a neutrophil activator. Nature 314:361–363
Wolff K, Hönigsmann H 1970) Permeability of the epidermis and the phagocytic activity of keratinocytes. Ultrastructural studies with thorotrast as marker. J Ultrastruct Res 36:176–190
Wolff K, Stingl G (1983) The Langerhans cell. J Invest Dermatol 80:17–21
Yaar M, Palleroni AV, Gilchrest BA (1986) Normal human epidermis contains an interferon-like protein. J Cell Biol 103:1349–1354
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kapp, A., Danner, M., Luger, T.A. et al. Granulocyte-activating mediators (GRAM). Arch Dermatol Res 279, 470–477 (1987). https://doi.org/10.1007/BF00412594
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00412594